What research tells us about quitting nicotine pouches

If you want to quit nicotine pouches, the research can help you ask better questions. It cannot yet give you a precise personal forecast or establish that the taper in an app is the best method for you.

An earlier version of this page said nobody had studied quitting pouches. That was too broad. We have corrected it: research involving people who stop nicotine pouches exists, while important questions about treatment and withdrawal remain open.

A study of stopping pouches is not a trial of quitting methods

A 2025 Swedish cohort study followed volunteers stopping tobacco or nicotine pouches for up to 12 weeks. Of 50 recruited volunteers, 37 stopped for at least three weeks and entered the analysis; 33 maintained cessation for all 12 weeks.

The researchers measured blood pressure and metabolic markers. They reported increases in average systolic home blood pressure, body weight, and HbA1c at 12 weeks. The study was small, included different pouch types, and had no randomized comparison of quitting methods. Its results do not show that quitting causes long-term harm, or that returning to nicotine would improve health.

It also cannot tell you whether tapering works better than stopping abruptly, or which night your sleep will improve. Those are different research questions.

What the larger smokeless-tobacco evidence says

A 2025 Cochrane review brought together 43 studies involving 20,346 people. It found that counselling, brief advice, and varenicline probably help people stop smokeless tobacco. Nicotine replacement therapy may also help, with less certainty in that finding.

These studies concern smokeless tobacco products, not a proven treatment protocol for tobacco-free nicotine pouches. They are relevant background for a conversation with a clinician, but the product difference matters. The review does not justify translating the nicotine printed on a pouch into a medication dose.

We also corrected the earlier wording here that dismissed a clear benefit from nicotine replacement without reflecting the review's more qualified conclusion.

How to read a claim about quitting

Before relying on a number or method, check three things:

1. Who was studied? People smoking cigarettes, using tobacco snus, and using tobacco-free nicotine pouches are not interchangeable groups.
2. What was measured? Reduced cravings, changes in blood pressure, and staying nicotine-free months later are different outcomes.
3. What was compared? Following volunteers after they stop can describe changes. Randomly comparing treatments answers a different question about which approach helps more people.

A confident headline can blur all three. You should be able to find these details in the source before treating its result as a promise about your own quit attempt.

What you can use now

General nicotine-withdrawal guidance provides a starting point for planning. Our withdrawal timeline keeps those ranges separate from pouch-specific evidence. The sleep guide does the same for nighttime difficulties.

If you are choosing between stopping and reducing first, read the cold turkey versus taper comparison, then discuss support with a pharmacist or clinician if previous attempts have been difficult. Bring your daily count, strength, other nicotine use, and the situations that tend to pull you back.

Coldsnap is being built to help people record use and follow a plan. It has not been clinically tested as a cessation treatment. A useful tracking tool and a treatment shown to improve quit rates are different claims, and we will keep that distinction visible as the research develops.